Fact CheckerSign in

NCT05889546Recruiting

Rapid Autopsy Protocol for Patients With Small Cell Lung Cancer

Rapid ("Warm") Autopsy Protocol for Patients With Small Cell Lung Cancer

Source: ClinicalTrials.gov · Last updated 14 Jul 2026

Brief summary (registry, in English)

This is pilot study to establish a rapid autopsy program in Small Cell Lung Cancer (SCLC) at the Indiana University Simon Comprehensive Cancer Center and outline the components necessary for tumor tissue collection.

Status (registry)
Recruiting
Study type
Observational
Enrollment
30 (estimated)
First submitted
22 May 2023
Start date
31 Aug 2022
Primary completion date
31 Dec 2030
Lead sponsor
Indiana University
Diseases
Lung cancer
NCT number
NCT05889546

What you commit to

  • Study type: Observational
  • Planned participants: 30
  • From 31 Aug 2022 to the primary completion date, 31 Dec 2030
  • 3 sites in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Who the study is looking for

  • ≥ 18 years old at the time of informed consent
  • Written informed consent and HIPAA authorization for release of personal health information.
  • Active SCLC diagnosis.

Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (3)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
Sidney and Lois Eskenazi Hospital
Coordinator of this site? Confirm its status
IndianapolisUnited StatesRecruiting
Roudebush VA Medical Center
Coordinator of this site? Confirm its status
IndianapolisUnited StatesRecruiting
Indiana University Melvin and Bren Simon Comprehensive Cancer Center
Coordinator of this site? Confirm its status
IndianapolisUnited StatesRecruiting

This page is information, not medical advice. Discuss any trial with your doctor.